| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjusting Cyclophosphamide Dose in Obese Patients with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation
|
Bachanova, Veronika
|
|
2016
|
22 |
3 |
p. 571-574
4 p.
|
artikel
|
| 2 |
A Genetic Modifier of the Gut Microbiome Influences the Risk of Graft-versus-Host Disease and Bacteremia After Hematopoietic Stem Cell Transplantation
|
Rayes, Ahmad
|
|
2016
|
22 |
3 |
p. 418-422
5 p.
|
artikel
|
| 3 |
Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD
|
Ho, Anthony D.
|
|
2016
|
22 |
3 |
p. 462-469
8 p.
|
artikel
|
| 4 |
A Standard Nonmyeloablative Transplantation Regimen for Adults with Sickle Cell Disease: Are We There Yet?
|
Hsieh, Matthew M.
|
|
2016
|
22 |
3 |
p. 397-398
2 p.
|
artikel
|
| 5 |
Bone Marrow Harvesting of Allogeneic Donors in an Outpatient Setting: A Single-Center Experience
|
Lisenko, Katharina
|
|
2016
|
22 |
3 |
p. 470-474
5 p.
|
artikel
|
| 6 |
Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan–Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation
|
Patel, Khilna
|
|
2016
|
22 |
3 |
p. 456-461
6 p.
|
artikel
|
| 7 |
Correlation of Pain and Fluoride Concentration in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Voriconazole
|
Barajas, Megan R.
|
|
2016
|
22 |
3 |
p. 579-583
5 p.
|
artikel
|
| 8 |
Developing a Risk Prediction Model for Long-Term Physical and Psychological Functioning after Hematopoietic Cell Transplantation
|
Braamse, Annemarie M.J.
|
|
2016
|
22 |
3 |
p. 549-556
8 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2016
|
22 |
3 |
p. A2-
1 p.
|
artikel
|
| 10 |
European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards
|
Anthias, Chloe
|
|
2016
|
22 |
3 |
p. 514-519
6 p.
|
artikel
|
| 11 |
Functionally Active HIV-Specific T Cells that Target Gag and Nef Can Be Expanded from Virus-Naïve Donors and Target a Range of Viral Epitopes: Implications for a Cure Strategy after Allogeneic Hematopoietic Stem Cell Transplantation
|
Patel, Shabnum
|
|
2016
|
22 |
3 |
p. 536-541
6 p.
|
artikel
|
| 12 |
Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation
|
Teusink, Ashley
|
|
2016
|
22 |
3 |
p. 482-486
5 p.
|
artikel
|
| 13 |
Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Children with Advanced Acute Leukemia with Fludarabine-, Busulfan-, and Melphalan-Based Conditioning
|
Jaiswal, Sarita Rani
|
|
2016
|
22 |
3 |
p. 499-504
6 p.
|
artikel
|
| 14 |
Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment
|
Dalle, Jean-Hugues
|
|
2016
|
22 |
3 |
p. 400-409
10 p.
|
artikel
|
| 15 |
High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry
|
Martino, Massimo
|
|
2016
|
22 |
3 |
p. 475-481
7 p.
|
artikel
|
| 16 |
Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation
|
Brunstein, Claudio G.
|
|
2016
|
22 |
3 |
p. 487-492
6 p.
|
artikel
|
| 17 |
Implications and Management of Central Nervous System Involvement before Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia
|
Aldoss, Ibrahim
|
|
2016
|
22 |
3 |
p. 575-578
4 p.
|
artikel
|
| 18 |
Influence of Differently Licensed KIR2DL1-Positive Natural Killer Cells in Transplant Recipients with Acute Leukemia: A Japanese National Registry Study
|
Arima, Nobuyoshi
|
|
2016
|
22 |
3 |
p. 423-431
9 p.
|
artikel
|
| 19 |
Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
|
Arora, Mukta
|
|
2016
|
22 |
3 |
p. 449-455
7 p.
|
artikel
|
| 20 |
Masthead (Purpose and Scope)
|
|
|
2016
|
22 |
3 |
p. A1-
1 p.
|
artikel
|
| 21 |
Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease
|
Saraf, Santosh L.
|
|
2016
|
22 |
3 |
p. 441-448
8 p.
|
artikel
|
| 22 |
Observational Studies: Matching or Regression?
|
Brazauskas, Ruta
|
|
2016
|
22 |
3 |
p. 557-563
7 p.
|
artikel
|
| 23 |
Officers and Directors of ASBMT
|
|
|
2016
|
22 |
3 |
p. A4-
1 p.
|
artikel
|
| 24 |
On Modeling Human Leukocyte Antigen–Identical Sibling Match Probability for Allogeneic Hematopoietic Cell Transplantation: Estimating the Need for an Unrelated Donor Source
|
Besse, Kelsey
|
|
2016
|
22 |
3 |
p. 410-417
8 p.
|
artikel
|
| 25 |
Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation
|
Bayraktar, Ulas D.
|
|
2016
|
22 |
3 |
p. 505-513
9 p.
|
artikel
|
| 26 |
Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico
|
Orti, Guillermo
|
|
2016
|
22 |
3 |
p. 584-588
5 p.
|
artikel
|
| 27 |
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors
|
Shanavas, Mohamed
|
|
2016
|
22 |
3 |
p. 432-440
9 p.
|
artikel
|
| 28 |
Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning
|
Brammer, Jonathan E.
|
|
2016
|
22 |
3 |
p. 493-498
6 p.
|
artikel
|
| 29 |
Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index
|
Kmeid, Joumana
|
|
2016
|
22 |
3 |
p. 542-548
7 p.
|
artikel
|
| 30 |
Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients
|
Halasa, Natasha B.
|
|
2016
|
22 |
3 |
p. 528-535
8 p.
|
artikel
|
| 31 |
Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers
|
Anthias, Chloe
|
|
2016
|
22 |
3 |
p. 520-527
8 p.
|
artikel
|
| 32 |
Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum
|
Barba, Pere
|
|
2016
|
22 |
3 |
p. 564-570
7 p.
|
artikel
|
| 33 |
Table of Contents
|
|
|
2016
|
22 |
3 |
p. A7-A8
nvt p.
|
artikel
|
| 34 |
To Match or Not to Match in Cord Blood Transplantation: A Modern Look at a Recurring Question
|
Kurtzberg, Joanne
|
|
2016
|
22 |
3 |
p. 398-399
2 p.
|
artikel
|
Tijdschrift beschrijving